Jeffrey S. Farrow, See Remarks at Tarsus Pharmaceuticals, Inc. (TARS), sold 14,396 shares at $60.95 ($877K) on 2026-06-16, disclosed to the SEC on 2026-06-17.
Open-market sale of $877k TARS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TARS | SELL | 2025-03-20 | $357K | — | Filing → |
| TARS | SELL | 2024-06-20 | $574K | — | Filing → |
| GBT | SELL | 2022-09-06 | $2.1M | — | Filing → |